Single-Cell Analysis Market Analysis

Single-Cell Analysis Industry Insights

Product Analysis

The consumables category held the larger share, around 65%, in 2024, and it will also grow faster during the forecast period. This is due to the increasing demand for isolation products, continuous purchase of reagents for research, and constant need for assay kits. An increase in the prevalence of target diseases and the continuous requirement for different products for exosome analysis and isolation of the DNA and RNA are also propelling the growth of this category.

The technological advancements in software tools, high-throughput assays, microfluidics, gene sequencing, and single cell amplification products and the widening availability of these products to healthcare settings, diagnostic laboratories, and academic institutions contribute in driving the sales growth.

The demand for instruments is growing at a lucrative rate, as they possess technically advanced features and superior clinical accuracy. Among instruments, NGS systems dominate the sales, as a large number of cells can be analyzed in a short period using this technology.

These products are part of the research scope:

• Consumables (Larger and Faster-Growing Category)
  • Beads
  • Microplates
  • Reagents
  • Assay kits
  • Others
• Instruments
  • Flow cytometers
  • NGS systems
  • PCR instruments
  • Spectrophotometers
  • Microscopes
  • Cell counters
  • Others

Application Analysis

Oncology dominates the market, and it also has the highest CAGR, of 12%, because researchers believe that single-cell analysis is the most effective for the diagnosis of cancer.

The most-widely occurring cancers are breast, lung, colon, rectum, and prostate cancers. According to the American Cancer Society, after coronary illnesses, cancer continues to be the second-biggest reason of death in the U.S. In 2022, a total of 1.9 million cases of cancer and about 609,360 deaths are expected. Moreover, it is estimated that about 8 in 10 deaths from lung cancer result from smoking cigarettes and exposure to radon gas.

Further, according to the WHO, in low-and-middle-income countries, about 30% of the cancer cases are due to the human papillomavirus. Moreover, researchers in the U.S. estimate that about 1 in 8 U.S. women will develop breast cancer during their life. Moreover, as per government reports, it is estimated that about 10,470 children and 5,480 adolescents will be diagnosed with cancer each year.

It is necessary to detect cancer at an early stage, to reduce the number of deaths. An increase in the prevalence of this disease is, thus, driving the market for single-cell analysis.

We analyzed these applications:

• Oncology (Largest and Fastest-Growing Category)
• Stem Cell
• Neurology
• Non-Invasive Prenatal Diagnosis
• Immunology
• In-Vitro Fertilization
• Others

End User Analysis

Academic and research laboratories hold the largest share, of 45%, in 2024 due to the introduction of spatial genomics. Moreover, the development of new tools and technological advancements, such as the use of microfluidics, are driving the market for single-cell analysis. The growth is essentially because of a significant increase in the number of research and academic laboratories.

Biotechnology and biopharmaceutical companies are witnessing the fastest growth in the market, on account of the rising biologics R&D and increasing preference for personalized medicine. There are three key challenges that persist to occur in the development of these biologic drugs: establishing product similarity, product toxicity, and global accessibility. These can be overcome by techniques that facilitate the isolation and interrogation of single cells in biotechnology companies. Factors such as high prevalence of cancer and infectious diseases, increasing healthcare expenditure, and growth in the Asian biotechnology companies drive the growth of this market.

The report provides analysis of the below-mentioned end users:

• Hospitals & Diagnostic Laboratories
• Cell Banks & IVF Centers
• Biotechnology & Biopharma Companies (Fastest-Growing Category)
• Academic & research Laboratories (Largest Category)

Cell Type Analysis

Human cells are the largest category, and they will also witness the highest CAGR during the forecast period. This is due to the increasing investment in stem cell research, and increasing prevalence of infectious diseases among the geriatric population. Human cells help in understanding the molecular and genetic basis of cancer, and various other infectious diseases. Various research studies are carried out on human cell for the purpose of diagnosing diseases at a better level. Stems cells have been extensively used for research purpose and for providing new treatment therapies.

The following cell types were studied:

• Human (Largest and Fastest-Growing Category)
• Animal
• Microbial